A meta-analysis on rituximab combined CHOP chemotherapy for non-Hodgkin lymphoma in China
Hou S, Yang W
 
 
Record Status
This is a systematic review that meets the criteria for inclusion on DARE.
Bibliographic details
Hou S, Yang W. A meta-analysis on rituximab combined CHOP chemotherapy for non-Hodgkin lymphoma in China. Saudi Medical Journal 2011; 32(7): 675-678
PubMedID
21748202
Original Paper URL
http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0031195/
Indexing Status
Subject indexing assigned by NLM
MeSH
Antibodies, Monoclonal, Murine-Derived /therapeutic use; Antineoplastic Agents /therapeutic use; Antineoplastic Combined Chemotherapy Protocols /therapeutic use; China; Cyclophosphamide /therapeutic use; Doxorubicin /therapeutic use; Humans; Lymphoma, Non-Hodgkin /drug therapy; Prednisone /therapeutic use; Rituximab; Vincristine /therapeutic use
AccessionNumber
12011005000
Date bibliographic record published
20/10/2011
 
Database of Abstracts of Reviews of Effects (DARE)
Produced by the Centre for Reviews and Dissemination
Copyright © 2026 University of York
 
Homepage
Options
Print
PDF
 
PubMed record
Original research
 
Share
 

Message for DARE database users